A neuropathologic diagnosis of Alzheimer’s disease in an older adult with HIV-associated neurocognitive disorder

References

• Abassi, M., Morawski, B. M., Nakigozi, G., Nakasujja, N., Kong, X., Meya, D. B., … Boulware, D. R. (2017). Cerebrospinal fluid biomarkers and HIV-associated neurocognitive disorders in HIV-indected individuals in Rakai, Uganda. Journal Neurovirology, 23, 369–375.
   PubMed Web of Science ®Google Scholar
• Ahmed, S., Baker, I., Thompson, S., Husain, M., & Butler, C. R. (2016). Utility of testing for apraxia and associated features in dementia. Journal of Neurology, Neurosurgery, and Psychiatry, 87, 1158–1162.
   PubMed Web of Science ®Google Scholar
• Ances, B. M., Christensen, J. J., Teshome, M., Taylor, J., Xiong, C., Aldea, P., … Clifford, D. B. (2010). Cognitively unimpaired HIV-positive subjects do not have increased 11C-PiB: A case-control study. Neurology, 75, 111–115.
   PubMed Web of Science ®Google Scholar
• Antinori, A., Arendt, G., Becker, J. T., Brew, B. J., Byrd, D. A., Cherner, M., … Wojna, V. E. (2007). Updated research nosology for HIV-associated neurocognitive disorders. Neurology, 69, 1789–1799.
   PubMed Web of Science ®Google Scholar
• Bearden, D. R., & Meyer, A. C. (2016). Should the Frascati criteria for HIV-associated neurocognitive disorders be used in children? Neurology, 87, 17–18.
   PubMed Web of Science ®Google Scholar
• Bell, J. E. (1998). The neuropathology of adult HIV infection. Revue neurologique, 154, 816–829.
   PubMed Web of Science ®Google Scholar
• Blennow, K. (2010). Biomarkers in Alzheimer’s disease drug development. Natural Medica, 16, 1218–1222.
   PubMed Web of Science ®Google Scholar
• Blennow, K., & Hampel, H. (2003). CSF markers for incipient Alzheimer’s disease. Lancet Neurologic, 2, 605–613.
   PubMed Web of Science ®Google Scholar
• Blennow, K., Mattsson, N., Schöll, M., Hansson, O., & Zetterberg, H. (2015). Amyloid biomarkers in Alzheimer’s disease. Trends Pharmacology Sciences, 36, 297–309.
   PubMed Web of Science ®Google Scholar
• Brew, B. J., Pemberton, L., Blennow, K., Wallin, A., & Hagberg, L. (2005). CSF amyloid β42 and tau levels correlate with AIDS dementia complex. Neurology, 65, 1490–1492.
   PubMed Web of Science ®Google Scholar
• Caine, D. (2004). Posterior cortical atrophy: A review of the literature. Neurocase, 10, 382–385.
   PubMed Web of Science ®Google Scholar
• CDC 2018 HIV among people aged 50 and over, viewed 27 February 2018, https://www.cdc.gov/hiv/group/age/olderamericans/
   Google Scholar
• Chiao, S., Rosen, H. J., Nicolas, K., Wendelken, L. A., Alcantar, O., Rankin, K. P., … Valcour, V. (2013). Deficits in self-awareness impact the diagnosis of asymptomatic neurocognitive impairment in HIV. AIDS Researcher Human Retrovir, 29, 949–956.
   PubMed Web of Science ®Google Scholar
• Ciccarelli, N., Fabbiani, M., Baldonero, E., Fanti, I., Cauda, R., Di Giambenedetto, S., & Silveri, M. C. (2012). Effect of aging and human immunodeficiency virus infection on cognitive abilities. Journal American Geriatrics Social, 60, 2048–2055.
   PubMed Web of Science ®Google Scholar
• Clifford, D. B., & Ances, B. M. (2013). HIV-associated neurocognitive disorder. Lancet Infection Diseases, 13, 976–986.
   PubMed Web of Science ®Google Scholar
• Clifford, D. B., Fagan, A. M., Holtzman, D. M., Morris, J. C., Teshome, M., Shah, A. R., & Kauwe, J. S. (2009). CSF biomarkers of Alzheimer disease in HIV-associated neurologic disease. Neurology, 73, 1982–1987.
   PubMed Web of Science ®Google Scholar
• Cysique, L. A., Hewitt, T., Croitoru-Lamoury, J., Taddei, K., Martins, R. N., Chew, C. S., … Brew, B. J. (2015). APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study. BMC Neurologic, 15, 51.
   PubMed Web of Science ®Google Scholar
• Delis, D., Peavy, G., Heaton, R., Butters, N., Salmon, D., Taylor, M., … McCutchan, J. A.; Grant I HNRC Group. (1995). Do patients with HIV-associated minor/motor disorder exhibit a “subcortical” memory profile? Evidence using the California verbal learning test. Assessment, 2, 151–156.
   Google Scholar
• Eden, A., Marcotte, T. D., Heaton, R. K., Nilsson, S., Zetterberg, H., Fuchs, D., … Gisslen, M. (2016). Increased intrathecal immune activation in virally suppressed HIV-1 infected patients with neurocognitive impairment. PLoS One, 11, e0157160.
   PubMed Web of Science ®Google Scholar
• Ferretti, F., Gisslen, M., Cinque, P., & Price, R. W. (2015). Cerebrospinal fluid HIV escape from antiretroviral therapy. Current HIV/AIDS Reports, 12, 280–288.
   PubMed Web of Science ®Google Scholar
• Friedman, L. S., Avila, S., Rizvi, T., Partida, R., & Friedman, D. (2017). Physical abuse of elderly adults: Victim characteristics and determinants of revictimization. Journal American Geriatrics Social, 65, 1420–1426.
   PubMed Web of Science ®Google Scholar
• Gelman, B. B. (2015). Neuropathology of HAND with suppressive antiretroviral therapy: Encephalitis and neurodegeneration reconsidered. Current HIV/AIDS Reports, 12, 272–279.
   PubMed Web of Science ®Google Scholar
• Greene, M., Justice, A. C., Lampiris, H. W., & Valcour, V. (2013). Management of human immunodeficiency virus infection in advanced age. JAMA, 309, 1397–1405.
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., Clifford, D. B., Franklin, J., Woods, S. P., Ake, C., Vaida, F., … Grant, I.; CHARTER Group. (2010). HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy. Neurology, 75, 2087–2096.
   PubMed Web of Science ®Google Scholar
• Heaton, R. K., & Franklin, D., Jr, Deutsch, R., Letendre, S., Ellis, R. J., Casaletto, K., … Smith, D. M.; Grant I CHARTER Group. (2015). Neurocognitive change in the era of HIV combination antiretroviral therapy: The longitudinal CHARTER study. Clinical Infectious Diseases, 60, 473–480
   Google Scholar
• Heaton, R. K., Franklin, D. R., Ellis, R. J., McCutchan, J. A., Letendre, S. L., Leblanc, S., … Grant, I. (2011). HIV-associated neurocognitive disorders before and during the era of combination antiretroviral therapy: Differences in rates, nature, and predictors. Journal of Neurovirology, 17, 3–16.
   PubMed Web of Science ®Google Scholar
• Herek, G. M., Capitanio, J. P., & Widaman, K. F. (2002). HIV-related stigma and knowledge in the United States: Prevalence and trends, 1991-1999. American Journal of Public Health, 92, 371–377.
   PubMed Web of Science ®Google Scholar
• Horvath, J., Burkhard, P. R., Herrmann, F. R., Bouras, C., & Kövari, E. (2014). Neuropathology of parkinsonism in patients with pure Alzheimer’s disease. Journal of Alzheimers Diseases, 39, 115–120.
   PubMed Web of Science ®Google Scholar
• Kojovic, M., Cordivari, C., & Bhatia, K. (2011). Myoclonic disorders: A practical approach for diagnosis and treatment. Therapeutic Advances in Neurological Disorders, 4, 47–62.
   PubMedGoogle Scholar
• Krut, J. J., Price, R. W., Zetterberg, H., Fuchs, D., Hagberg, L., Yilmaz, A., … Gisslén, M. (2017). No support for premature central nervous system aging in HIV-1 when measured by cerebrospinal fluid phosphorylated tau (p-tau). Virulence, 8, 599–604.
   PubMed Web of Science ®Google Scholar
• Mäkitalo, S., Mellgren, Å., Borgh, E., Kilander, L., Skillbäck, T., Zetterberg, H., & Gisslén, M. (2015). The cerebrospinal fluid biomarker profile in an HIV-infected subject with Alzheimer’s disease. AIDS Researcher Therapeutics, 12, 23.
   PubMed Web of Science ®Google Scholar
• Mattsson, N., Rosén, E., Hansson, O., Andreasen, N., Parnetti, L., Jonsson, M., … Zetterberg, H. (2012). Age and diagnostic performance of Alzheimer disease CSF biomarkers. Neurology, 78, 468–476.
   PubMed Web of Science ®Google Scholar
• Milanini, B., & Valcour, V. (2017). Differentiating HIV-associated neurocognitive disorders from Alzheimer’s disease: An emerging issue in geriatric neuroHIV. Current HIV/AIDS Reports, 14, 123–132.
   PubMed Web of Science ®Google Scholar
• Murji, S., Rourke, S. B., Donders, J., Carter, S. L., Shore, D., & Rourke, B. P. (2003). Theoretically derived CVLT subtypes in HIV-1 infection: Internal and external validation. Journal of the International Neuropsychological Society, 9, 1–16.
   PubMed Web of Science ®Google Scholar
• Ossenkoppele, R., Jansen, W. J., Rabinovici, G. D., Knol, D. L., van der Flier, W. M., van Berckel, B. N., … Visser, P. J. (2015). Prevalence of amyloid PET positivity in dementia syndromes: A meta-analysis. JAMA, 313, 1939–1949.
   PubMed Web of Science ®Google Scholar
• Snowden, M. B., Bowen, J. D., Hughes, J., & Larson, E. B. (1995). Study of Alzheimer’s dementia patients with parkinsonian features. Journal Geriatrics Psychiatry Neurologic, 8, 154–158.
   PubMed Web of Science ®Google Scholar
• Turner, R. S., Chadwick, M., Horton, W. A., Simon, G. L., Jiang, X., & Esposito, G. (2016). An individual with human immunodeficiency virus, dementia, and central nervous system amyloid deposition. Alzheimers Dement (Amst), 4, 1–5.
   PubMedGoogle Scholar
• Valcour, V., Watters, M. R., Williams, A. E., Sacktor, N., McMurtray, A., & Shikuma, C. (2008). Aging exacerbates extrapyramidal motor signs in the era of highly active antiretroviral therapy. Journal of Neurovirology, 14, 362–367.
   PubMed Web of Science ®Google Scholar
• Walker, R. E., Parker, R. I., Kovacs, J. A., Masur, H., Lane, H. C., Carelton, S., … Fauci, A. S. (1988). Anemia and erythropoiesis in patients with the acquired immunodeficiency syndrome (AIDS) and Kaposi sarcoma treated with zidovudine. Annals of Internal Medicine, 108, 372–376.
   PubMed Web of Science ®Google Scholar
• Weintraub, S., Wicklund, A. H., & Salmon, D. P. (2012). The neuropsychological profile of Alzheimer disease. Cold Spring Harbor Perspectives in Medicine, 2, a006171.
   PubMed Web of Science ®Google Scholar
• Woods, S. P., Moore, D. J., Weber, E., & Grant, I. (2009). Cognitive neuropsychology of HIV-associated neurocognitive disorders. Neuropsychology Review, 19, 152–168.
   PubMed Web of Science ®Google Scholar